OTHER PROCESS TECHNOLOGIES Sample Clauses

OTHER PROCESS TECHNOLOGIES. 3.1.1.3.1 If during the Term of the Agreement WEITEK desires to implement MIPS Chips, based on the deliverables provided in CMOS specified in Exhibit A in any Process Technology other than CMOS or Bi-CMOS, then WEITEK shall pay to MIPS a onetime, up-front, non-recoverable license fee of [*] for each additional Process Technology other than CMOS or Bi-CMOS per new Generation in which WEITEK intends to implement. Said fee shall be payable within thirty (30) days of notice by WEITEK to MIPS that WEITEK intends to commence work to implement the deliverables provided in CMOS in another Process Technology.
Sample 1Sample 2
AutoNDA by SimpleDocs
OTHER PROCESS TECHNOLOGIES. 3.1.1.3.1 If during the Term of the Agreement WEITEK desires to implement MIPS Chips, based on the deliverables provided in CMOS specified in Exhibit A in any Process Technology other than CMOS or Bi-CMOS, then WEITEK shall pay to MIPS a onetime, up-front, non-recoverable license fee of $1,000,000 for each additional Process Technology other than CMOS or Bi-CMOS per new Generation in which WEITEK intends to implement. Said fee shall be payable within thirty (30) days of notice by WEITEK to MIPS that WEITEK intends to commence work to implement the deliverables provided in CMOS in another Process Technology. 3.1.1.3.2 If during the Term of this Agreement WEITEK desires to implement MIPS Chips based upon deliverables which may be subsequently available from MIPS in any Process Technology other than CMOS, then WEITEK shall pay to MIPS, MIPS then current license fee for each additional Process Technology per new Generation. Said fee shall be payable within thirty (30) days of receipt by WEITEK from MIPS of the deliverables implemented in any Process Technology other than CMOS. 3.1.2
Sample 1

Related to OTHER PROCESS TECHNOLOGIES

  • Technology Discoveries, innovations, Know-How and inventions, whether patentable or not, including computer software, recognized under U.S. law as intellectual creations to which rights of ownership accrue, including, but not limited to, patents, trade secrets, maskworks and copyrights developed under this Agreement.

  • Background Technology List here prior contracts to assign Inventions that are now in existence between any other person or entity and you. [ ] List here previous Inventions which you desire to have specifically excluded from the operation of this Agreement. Continue on reverse side if necessary.

  • New Technology When new or updated technology is introduced into a workplace, it will be the responsibility of the employer to provide appropriate and, if necessary, ongoing training to the employees directly affected. Such training will include any health and safety implications or information that will enable employees to operate the equipment without discomfort and will help maintain their general well-being.

  • Manufacturing (a) The Supplier shall without limitation be responsible, at no additional cost to the Purchaser, for: sourcing and procuring all raw materials for the Products; obtaining all necessary approvals, permits and licenses for the manufacturing of the Products; providing sufficient qualified staff and workers to perform the obligations under this Purchase Agreement; implementing and maintaining effective inventory and production control procedures with respect to the Products; and handling other matters as reasonably requested by the Purchaser from time to time.

  • Manufacturing Technology Transfer With respect to each Technology Transfer Product, upon AbbVie’s written request after the Inclusion Date for the Included Target to which such Technology Transfer Product is Directed, Morphic shall effect a full transfer to AbbVie or its designee (which designee may be an Affiliate or a Third Party manufacturer) of all Morphic Know-How and Joint Know-How relating to the then-current process for the Manufacture of such Technology Transfer Product (the “Manufacturing Process”) and to implement the Manufacturing Process at facilities designated by AbbVie (such transfer and implementation, as more fully described in this Section 5.3, the “Manufacturing Technology Transfer”). To assist with the Manufacturing Technology Transfer, Morphic will make its personnel reasonably available to AbbVie during normal business hours for up to [***] FTE hours with respect to each Included Target (in each case, free of charge to AbbVie) to transfer and implement the Manufacturing Process under this Section 5.3. Thereafter, if requested by AbbVie, Morphic shall continue to perform such obligations; provided, that AbbVie will reimburse Morphic for its full-time equivalent (FTE) costs (for clarity, in excess of [***] FTE hours) and any reasonable and verifiable out-of-pocket costs incurred in providing such assistance. CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY [***], HAS BEEN OMITTED BECAUSE IT IS NOT MATERIAL AND WOULD LIKELY CAUSE COMPETITIVE HARM TO THE COMPANY IF PUBLICLY DISCLOSED.

  • Licensed Technology The term "Licensed Technology" shall mean the ------------------- Licensed Patents, plus all improvements thereto developed by Licensor, and all related data, know-how and technology.

  • Other Products After clinical or other evidence, provided in writing [***] to Company, demonstrating the practicality of a particular market or use within the LICENSED FIELD which is not being developed or commercialized by Company, Company shall either provide JHU with a reasonable development plan and start development or attempt to reasonably sublicense the particular market or use to a third party. If within six (6) months of such notification [***] Company has not initiated such development efforts or sublicensed that particular market or use, JHU may terminate this license for such particular market or use. This Paragraph shall not be applicable if Company reasonably demonstrates to JHU that commercializing such LICENSED PRODUCT(S) or LICENSED SERVICE(S) or granting such a sublicense in said market or use would have a potentially adverse commercial effect upon marketing or sales of the LICENSED PRODUCT(S) developed and being sold by Company.

  • Background IP Each Party will own all right, title and interest in its Background IP.

  • Third Party Technology The Company makes use of third party technology to collect information required for traffic measurement, research, and analytics. Use of third party technology entails data collection. We therefore would like to inform clients the Company enables third parties to place or read cookies located on the browsers of users entering the Company’s domain. Said third parties may also use web beacons to collect information through advertising located on the Company’s web site. Please note that you may change your browser settings to refuse or disable Local Shared Objects and similar technologies; however, by doing so you may be disabling some of the functionality of Company’s services.

Time is Money Join Law Insider Premium to draft better contracts faster.